To test the hypothesis that a carb-restricted diet can simultaneously improve the cluster of markers for metabolic syndrome, which can be understood as a carbohydrate-sensitive mechanism.

27
2009
1
"To test the hypothesis that a carb-restricted diet can simultaneously improve the cluster of markers for metabolic syndrome, which can be understood as a carbohydrate-sensitive mechanism. To investigate the impacts of a low-carb diet on metabolic syndrome, compared to a LF diet."
N
40
"Aim of diet was to induce a low level of ketosis Targets E: ~1500kcal/d Carb: 12%E Protein: 28%E Fat: 59%E Intake E: 1504kcal/d Carb: 44.8g/d, 12.4%E Protein: 104.8g/d; 28.1%E Fat: 100.2g/d, 58.9%E (36.4g/d saturated fat)"
"Lowfat diet Subjects instructed on foods allowed and to avoid. Targets E: ~1500kcal/d Carb: ~55%E Protein: ~20%E Fat: ~24%E (10%E from saturated fat; <300mg cholestrol/d). Intake E: 1478kcal/d Carb: 208.3g/d, 55.8%E Protein: 71.5g/d; 19.6%E Fat: 40.0g/d, 23.8%E (11.7g/d saturated fat)"
"Primary: markers of metabolic syndrome - lipid levels, HDL:total C ratio, fasting insulin, FBG, insulin area under the curve (AUC); weight, BMI and body composition, insulin sensitivity. Secondary: markers of CVD risk - postprandial lipemia, Apob:ApoA ratio, LDL particle distribution, serum retinol binding protein 4 (linked to insulin-resistant states)."
"Fasting glucose WG: NR BG: Y Baseline→12 weeks LC diet 101mg/dL→89 LF diet 96mg/dL→94 BG SS p=0.006"
*
1
NR
*
*
"WG: NR BG: N BG NSS"
*
0
"WG: NR BG: Y Baseline→12 weeks LC diet 36mg/dL→40 LF diet 39mg/dL→38 BG SS p=0"
*
1
"WG: NR BG: N BG NSS"
*
0
"WG: NR BG: Y Baseline→12 weeks TG LC diet 211mg/dL→104 (-51%) LF diet 187mg/dL→151 (-19%) BG SS p=0 TG:HDL ratio LC diet: -54% LF diet: -20% BG SS p<0.001 TG AUC After 12 weeks, the postprandial test at 6 hours after high-fat meal found the AUCs for the 2 diets, compared to baseline were: LC diet: -47% F diet: -15%"
*
1
*
*
"Weight, BMI, fat mass, abdominal fat WG: NR BG: Y Baseline→12 weeks Weight LC diet 95.5kg→86.4 (-10.5%) LF diet 94.4→89.2 (-5.8%) BG SS p=0.00 BMI LC diet 33.5→30.0 LF diet 32.1→30.3 BG SS p=0.00 Fat mass reduction was SS more with LC diet. p=0.009 SS more lean mass was lost on LC diet (6.3% vs 1.8%). p=0.009 Abdominal fat loss SS greater on LC diet. % body fat loss BG NSS."
*
1
NR
*
*
NR
*
*
"Fasting insulin & insulin AUC WG: NR BG: Y Baseline→12 weeks Fasting insulin LC diet 107pmol/L→54 LF diet 70pmol/L→57 BG SS p=0.017 "
*
1
"HOMA WG: NR BG: Y Baseline→12 weeks LC diet 2.9→1.3 LF diet 1.7→1.4 BG SS p=0.009 "
*
1
NR
*
*
NR
NR
"ApoB:ApoA-1 ratio: worsened on LF diet, improved on LC diet. BG SS p=0.001. Leptin (3 measures): On all 3, the LC diet lowered leptin to a SS greater degree than LF diet. BG SS p varied. Total saturated fat acids reduced 57% in LC diet vs 24% in LF diet. LDL particle patterns: the LC diet improved particle size (larger) and reduced the amount of small and very smal LDL particles, SS BG. "
"...a diet restricted in carblhydrate can provide a more comprehensive improvement in the clinical risk factors associated with MetS than a LF diet at reduced caloric intake. ... carbohydrate restriction has the ability to target the range of markers [for MetS] with a single intervention. That this collection of ... markers responds in concert to carbohydrate restriction provides support for considering them as a single syndrome ... Low-carbohydrate diets therefore represent an alternative strategy for general health beyond weight regulation."

Abbreviations:

AHA - American Heart Association;
ALT - alanine aminotransferase;
AMDR - acceptable macronutrient distribution range;
AST - aspartate aminotransferase;
BG - between study groups;
BHOB - beta-hydroxybutyrate;
DBP - diastolic blood pressure;
E- energy, caloric intake;
eGFR - estimated glomerular filtration rate;
FBG - fasting blood glucose;
GGT - gamma-glutamyl transferase;
HDL-C - high-density lipoprotein cholesterol;
iGFR - isotope glomerurar filtration rate;
LDL-C - low-density lipoprotein cholesterol;
NAFLD - non-alcoholic fatty liver disease;
NR - not reported (or data needed for calculation not available);
N - no;
NA - not applicable;
NS - not specified;
NSS - not statistically significant;
SBP - systolic blood pressure;
SS - statistically significant;
TG - triglyceride;
total C - total cholesterol;
V - varied, mixed;
WG - within a study group;
WMD - weighted mean difference;
Y - yes

Number of People in Studies:

3,296 Enrolled in randomized controlled trials on 25% or less carbohydrates
2,626 Completed randomized controlled trials on 25% or less carbohydrates
79.67% 82% completion of studies

Duration of Trial

<6 Months
6-9 Months
1 -2 years
>2 years

# of Trials

36
6
9s
1

Join the Low-Carb Action Network to stay informed of our latest news and calls to action.


Don't miss out on the chance to lend your voice for change!

We will never sell or share our mailing list with any other party or organization